RESUMEN

BACKGROUND: Clinicians may be less inclined to consider a diagnosis of cryptococcal meningitis in people without HIV infection or transplant-related immunosuppression. This may lead to a delay in diagnosis particularly if disseminated cryptococcal disease mimics cerebral septic emboli in injection drug use (IDU) leading to a search for endocarditis or other infectious sources. Though, IDU has been described as a potential risk for disseminated cryptococcal disease. CASE PRESENTATIONS: We present two cases of cryptococcal meningitis in IDU without HIV or other obvious immune deficits. Both patients presented with at least 2 weeks of headache and blurred vision. They developed central nervous system (CNS) vasculitis, one of which mimicked septic cerebral emboli, but both resulted with poor neurologic outcomes. CONCLUSIONS: IDU likely induces an underappreciated immune deficit and is a risk factor for developing cryptococcal meningitis. This diagnosis, which can mimic cerebral septic emboli through involvement of a CNS vasculitis, should be considered in the setting of IDU.

Asunto(s)

Drogas Ilícitas/efectos adversos , Embolia Intracraneal/microbiología , Meningitis Criptocócica/diagnóstico , Trastornos Relacionados con Sustancias/complicaciones , Adulto , Cryptococcus neoformans/genética , Cryptococcus neoformans/aislamiento & purificación , Humanos , Embolia Intracraneal/diagnóstico , Embolia Intracraneal/etiología , Embolia Intracraneal/inmunología , Masculino , Meningitis Criptocócica/etiología , Meningitis Criptocócica/inmunología , Meningitis Criptocócica/microbiología , Persona de Mediana Edad , Proyectos de Investigación , Factores de Riesgo

RESUMEN

We design and synthesize EpCAM antibodies with Fc-domain site-specific linkers that allow preferential alignment when coated on microfluidic devices for capturing circulating tumor cells (CTCs) from colorectal cancer patients. The aligned coating is shown to increase the capture efficiency of CTCs and microemboli by 1.6 and 3.0-fold, respectively (both P < 0.05).

Asunto(s)

Anticuerpos Inmovilizados/química , Anticuerpos Inmovilizados/inmunología , Separación Celular/métodos , Neoplasias Colorrectales/patología , Embolia Intracraneal/patología , Técnicas Analíticas Microfluídicas , Células Neoplásicas Circulantes/patología , Neoplasias Colorrectales/inmunología , Ensayo de Inmunoadsorción Enzimática , Humanos , Embolia Intracraneal/inmunología , Conformación Molecular , Células Neoplásicas Circulantes/inmunología

Asunto(s)

Encéfalo/inmunología , Embolia Intracraneal/inmunología , Embolia Intracraneal/terapia , Accidente Cerebrovascular/inmunología , Accidente Cerebrovascular/terapia , Animales , Quimiocinas/metabolismo , Citocinas/metabolismo , Citometría de Flujo , Granulocitos/inmunología , Humanos , Activación de Macrófagos/inmunología , Ratones , Microglía/inmunología , Terapia Trombolítica

RESUMEN

AIMS: Epidemiological studies suggest that sex has a role in the pathogenesis of cardioembolic stroke. Since stroke is a vascular disease, identifying sexually dimorphic gene expression changes in blood leukocytes can inform on sex-specific risk factors, response and outcome biology. We aimed to examine the sexually dimorphic immune response following cardioembolic stroke by studying the differential gene expression in peripheral white blood cells. METHODS AND RESULTS: Blood samples from patients with cardioembolic stroke were obtained at ≤3 hours (prior to treatment), 5 hours and 24 hours (after treatment) after stroke onset (n = 23; 69 samples) and compared with vascular risk factor controls without symptomatic vascular diseases (n = 23, 23 samples) (ANCOVA, false discovery rate p≤0.05, |fold change| ≥1.2). mRNA levels were measured on whole-genome Affymetrix microarrays. There were more up-regulated than down-regulated genes in both sexes, and females had more differentially expressed genes than males following cardioembolic stroke. Female gene expression was associated with cell death and survival, cell-cell signaling and inflammation. Male gene expression was associated with cellular assembly, organization and compromise. Immune response pathways were over represented at ≤3, 5 and 24 h after stroke in female subjects but only at 24 h in males. Neutrophil-specific genes were differentially expressed at 3, 5 and 24 h in females but only at 5 h and 24 h in males. CONCLUSIONS: There are sexually dimorphic immune cell expression profiles following cardioembolic stroke. Future studies are needed to confirm the findings using qRT-PCR in an independent cohort, to determine how they relate to risk and outcome, and to compare to other causes of ischemic stroke.

Asunto(s)

Regulación de la Expresión Génica , Embolia Intracraneal/inmunología , Leucocitos/metabolismo , Caracteres Sexuales , Anciano , Anciano de 80 o más Años , Eritroblastos/metabolismo , Femenino , Perfilación de la Expresión Génica , Redes Reguladoras de Genes , Cardiopatías/complicaciones , Humanos , Inflamación/genética , Embolia Intracraneal/sangre , Embolia Intracraneal/etiología , Embolia Intracraneal/genética , Masculino , Megacariocitos/metabolismo , Persona de Mediana Edad , Datos de Secuencia Molecular , Monocitos/metabolismo , Neutrófilos/metabolismo , Factores de Tiempo , Factores de Transcripción/metabolismo

RESUMEN

Increased levels of proinflammatory cytokines have been recorded after the onset of transient or permanent brain ischemia and are usually associated with exacerbation of ischemic injury. Embolic stroke model is more relevant to the pathophysiological situation in such patients, because the majority of ischemic injuries in humans are induced by old thrombi that originate from the heart and carotid arteries. Therefore, the aim of the present study was to investigate changes of inflammatory cytokines after embolic stroke. Rats were subjected to embolic stroke, induced by a natural old clot which was injected in Middle Cerebral Artery (MCA), or sham stroke, which the same volume of saline was injected into the MCA. At 48 h after stroke induction, the levels of 5 cytokines (IL-1α and ß, IL-6, IFN-γ and TNF-α) were determined in 500 µg of total protein using the Bio-Plex Rat Cytokine Array (BioRad), according to the manufacturer's instructions in ischemic and non-ischemic cortices. While stroke animals showed infarctions and neurological deficits, we did not observe any cerebral infarction and neurological deficits in sham-operated animals. The levels of IL-1α (p=0.000) and -ß (p =0.004), IL-6 (p =0.008), TNF-α (p =0.000) and IFN-γ (p =0.044) were significantly increased compared to sham treated animals. The findings of the present study suggest that part of ischemic injury in the embolic stroke may be mediated through the increased levels of inflammatory cytokines.

Asunto(s)

Isquemia Encefálica/inmunología , Corteza Cerebral/inmunología , Citocinas/inmunología , Embolia Intracraneal/inmunología , Animales , Isquemia Encefálica/metabolismo , Isquemia Encefálica/patología , Corteza Cerebral/metabolismo , Corteza Cerebral/patología , Citocinas/metabolismo , Modelos Animales de Enfermedad , Humanos , Embolia Intracraneal/metabolismo , Embolia Intracraneal/patología , Masculino , Ratas , Ratas Wistar

RESUMEN

PURPOSE: To investigate serological predictors of risk for cerebral embolism after carotid artery stenting (CAS). METHODS: Twenty consecutive symptomatic and asymptomatic patients (13 men; mean age 74 years) with carotid artery stenosis undergoing standardized filter-protected CAS (Wallstent) were preoperatively evaluated to identify unstable plaque (duplex ultrasound), complicated aortic plaque (transesophageal echocardiography), and inflammatory status [high-sensitivity C-reactive protein (hs-CRP) and serum amyloid-A protein (SAA) serum levels]. Aortic arch type, carotid tortuosity, and complexity of the procedure were considered. Cerebral embolism was evaluated by comparing the number, volume, and side (ipsilateral and non-ipsilateral) of preoperative and postoperative cerebral lesions detected on diffusion-weighted resonance magnetic imaging (DW-MRI) and through light and scanning electron microscopy analysis of cerebral protection filters obtained from CAS. RESULTS: All CAS procedures were completed with no complications. All patients had a negative preoperative DW-MRI, but at least 1 asymptomatic cerebral lesion appeared on DW-MRI after the procedure in 18 (90%) patients. Female gender was associated with a higher number of cerebral lesions (18.2±10.9 vs. 8.3±8.8 for men, p=0.03). Carotid plaque morphology, supra-aortic vessel anatomy, and procedure complexity did not correlate with number or volume of new cerebral lesions. Complicated aortic plaque was associated with a higher volume of non-ipsilateral cerebral lesions than uncomplicated plaque (235.0±259.3 vs. 63.6±63.2 mm(3), respectively; p=0.02). Hs-CRP ≥5 mg/L and SAA ≥10 mg/L were significantly associated with a higher number of new cerebral lesions [16.2±10.7 vs. 4.3±3.4 for hs-CRP <5 mg/L (p=0.02) and 14.8±10.3 vs. 2.8±3.4 for SAA <10 mg/L (p=0.006), respectively]. Hs-CRP ≥5 mg/L and SAA ≥10 mg/L also correlated with greater surface involvement by embolic materials in the protection filters at microscopic analysis [37.0% (5.1%) vs. 26.9% (2.5%) for hs-CRP <5 mg/L, p=0.004; 35.9% (13.5%) vs. 22.2% (6.9%) for SAA <10 mg/L, p=0.02]. CONCLUSION: In addition to female gender and the presence of complicated aortic plaque, inflammatory status can be a predictor of cerebral embolism in CAS.

Asunto(s)

Angioplastia/efectos adversos , Angioplastia/instrumentación , Estenosis Carotídea/terapia , Mediadores de Inflamación/sangre , Embolia Intracraneal/etiología , Stents , Anciano , Anciano de 80 o más Años , Enfermedades de la Aorta/complicaciones , Enfermedades de la Aorta/diagnóstico por imagen , Enfermedades Asintomáticas , Biomarcadores/sangre , Estenosis Carotídea/sangre , Estenosis Carotídea/complicaciones , Estenosis Carotídea/diagnóstico por imagen , Estenosis Carotídea/inmunología , Imagen de Difusión por Resonancia Magnética , Ecocardiografía Transesofágica , Dispositivos de Protección Embólica , Femenino , Humanos , Embolia Intracraneal/sangre , Embolia Intracraneal/diagnóstico , Embolia Intracraneal/inmunología , Masculino , Microscopía Electrónica de Rastreo , Placa Aterosclerótica , Valor Predictivo de las Pruebas , Estudios Prospectivos , Diseño de Prótesis , Factores de Riesgo , Factores Sexuales , Resultado del Tratamiento , Ultrasonografía Doppler Dúplex

RESUMEN

BACKGROUND: Cerebral microembolic signals (MES) may predict increased stroke risk in carotid stenosis. However, the relationship between platelet counts or platelet activation status and MES in symptomatic vs. asymptomatic carotid stenosis has not been comprehensively assessed. SETTING: University teaching hospitals. METHODS: This prospective, pilot observational study assessed platelet counts and platelet activation status, and the relationship between platelet activation and MES in asymptomatic vs. early (≤ 4 weeks after TIA/stroke) and late phase (≥ 3 months) symptomatic moderate or severe (≥ 50%) carotid stenosis patients. Full blood count measurements were performed, and whole blood flow cytometry was used to quantify platelet surface activation marker expression (CD62P and CD63) and circulating leucocyte-platelet complexes. Bilateral simultaneous transcranial Doppler ultrasound monitoring of the middle cerebral arteries was performed for 1 h to classify patients as MES positive or MES negative. RESULTS: Data from 31 asymptomatic patients were compared with 46 symptomatic patients in the early phase, and 35 of these patients were followed up to the late phase after symptom onset. The median platelet count (211 vs. 200 × 10(9)  L(-1) ; P = 0.03) and the median percentage of lymphocyte-platelet complexes was higher in early symptomatic than asymptomatic patients (2.8 vs. 2.4%; P = 0.001). The percentage of lymphocyte-platelet complexes was higher in early symptomatic than in asymptomatic patients with ≥ 70% carotid stenosis (P = 0.0005) and symptomatic patients recruited within 7 days of symptom onset (P = 0.028). Complete TCD data were available in 25 asymptomatic, 31 early phase symptomatic and 27 late phase symptomatic patients. Twelve per cent of asymptomatic vs. 32% of early phase symptomatic (P = 0.02) and 19% of late phase symptomatic patients (P = 0.2) were MES positive. Early symptomatic MES-negative patients had a higher percentage of lymphocyte-platelet complexes than asymptomatic MES-negative patients (2.8 vs. 2.3%; P = 0.0085). DISCUSSION: Recently, symptomatic carotid stenosis patients have had higher platelet counts (potentially reflecting increased platelet production, mobilization or reduced clearance) and platelet activation status than asymptomatic patients. MES were more frequently detected in early symptomatic than asymptomatic patients, but the differences between late symptomatic and asymptomatic groups were not significant. Increased lymphocyte-platelet complex formation in recently symptomatic vs. asymptomatic MES-negative patients indicates enhanced platelet activation in this early symptomatic subgroup. Platelet biomarkers, in combination with TCD, have the potential to aid risk-stratification in asymptomatic and symptomatic carotid stenosis patients.

Asunto(s)

Estenosis Carotídea/sangre , Embolia Intracraneal/sangre , Activación Plaquetaria , Anciano , Enfermedades Asintomáticas , Biomarcadores/sangre , Estenosis Carotídea/complicaciones , Estenosis Carotídea/inmunología , Distribución de Chi-Cuadrado , Femenino , Citometría de Flujo , Hospitales de Enseñanza , Humanos , Embolia Intracraneal/diagnóstico por imagen , Embolia Intracraneal/inmunología , Ataque Isquémico Transitorio/sangre , Ataque Isquémico Transitorio/inmunología , Modelos Lineales , Linfocitos/inmunología , Masculino , Persona de Mediana Edad , Selectina-P/sangre , Proyectos Piloto , Recuento de Plaquetas , Valor Predictivo de las Pruebas , Estudios Prospectivos , Factores de Riesgo , Índice de Severidad de la Enfermedad , Accidente Cerebrovascular/sangre , Accidente Cerebrovascular/etiología , Tetraspanina 30/sangre , Factores de Tiempo , Ultrasonografía Doppler en Color , Ultrasonografía Doppler Transcraneal

Asunto(s)

Vasculitis Asociada a Anticuerpos Citoplasmáticos Antineutrófilos/inmunología , Endotelio Vascular/inmunología , Eosinófilos/inmunología , Síndrome Hipereosinofílico/inmunología , Lesión Renal Aguda/inmunología , Animales , Citotoxicidad Inmunológica/inmunología , Células Endoteliales/inmunología , Cardiopatías/inmunología , Humanos , Embolia Intracraneal/inmunología , Trombomodulina/antagonistas & inhibidores , Trombomodulina/sangre , Trombofilia/inmunología , Microangiopatías Trombóticas/inmunología

RESUMEN

BACKGROUND AND PURPOSE: Microemboli occur frequently in patients with asymptomatic carotid atherosclerosis. In other vascular beds, microemboli are known to initiate an inflammatory response, causing organ dysfunction. In the current study, we investigated whether emboli composed of cholesterol crystals, a component of human atherosclerotic plaque, could also cause inflammation and brain dysfunction demonstrated by cognitive impairment. METHODS: Cholesterol crystals of 60 to 100 microm were injected via the rat internal carotid artery. T2-weighted magnetic resonance imaging was conducted after 3 days to estimate infarct volume. Brains were examined for matrix metalloproteinase activation at 24 hours and for albumin leakage and microglia and astrocyte activation at 4 days and 1, 2, and 4 weeks after embolization. To determine changes in cognition, behavioral tests including open field, motor learning, and Barnes Maze tests were conducted on young adult and middle-aged rats 4 weeks after either a single injection or after repeated, bilateral injections given at an interval of 2 weeks. RESULTS: Matrix metalloproteinase activation was detected in 50% of the animals examined. Perivascular albumin staining was found at 4 days but rarely persisted beyond 1 week. Activation of microglia and astrocytes occurred in all animals and persisted for up to 8 weeks. Cognitive impairment was observed in middle-aged rats after repeated, bilateral injections but not after single injections. In these animals, areas of inflammation were small and scattered but often involved the striatum and hippocampus. CONCLUSIONS: Cholesterol embolization caused an inflammatory response in the brain with persistent activation of microglia and astrocytes and led to cognitive impairment after repeated injections in middle-aged animals with only small foci of neural injury. These data indicate that microembolization causes inflammation and that minimal neuronal injury can cause cognitive impairment in older animals.

Asunto(s)

Barrera Hematoencefálica/metabolismo , Colesterol/farmacocinética , Trastornos del Conocimiento/metabolismo , Embolia Intracraneal/metabolismo , Accidente Cerebrovascular/metabolismo , Factores de Edad , Animales , Conducta Animal , Barrera Hematoencefálica/patología , Enfermedades de las Arterias Carótidas/inmunología , Enfermedades de las Arterias Carótidas/metabolismo , Enfermedades de las Arterias Carótidas/patología , Arteria Carótida Interna , Colesterol/química , Trastornos del Conocimiento/inmunología , Trastornos del Conocimiento/patología , Cuerpo Estriado/patología , Cristalización , Modelos Animales de Enfermedad , Encefalitis/metabolismo , Encefalitis/patología , Hipocampo/patología , Embolia Intracraneal/inmunología , Embolia Intracraneal/patología , Masculino , Ratas , Ratas Sprague-Dawley , Accidente Cerebrovascular/inmunología , Accidente Cerebrovascular/patología

RESUMEN

Arterio-arterial emboli originating from a high-grade stenosis of the internal carotid artery are a common cause for cerebral ischemias. Inflammatory processes are not only pivotal in the development of atherosclerotic vessel wall changes, but also for their clinical destabilization. Inflammatory cells, like macrophages, can turn a chronic high-grade carotid stenosis into a high-risk area for the development of arterial thromboses by way of a complex pathogenesis involving the elevation of proinflammatory factors, biosynthesis of collagen-degrading matrix metalloproteinases and expression of prothrombotic tissue factor. This process could affect the occurrence of perioperative complications during carotid endarterectomies. Statins are potent cholesterol-lowering agents. Among other lipid-independent effects, statins appear to play a significant role in preventing cardiovascular events. A number of studies have shown that statins possess plaque-stabilizing effects and that they improve cerebral autoregulation. A growing evidence supports the preoperative administration of statins in patients with high-grade stenoses of the internal carotid artery.

Asunto(s)

Anticolesterolemiantes/uso terapéutico , Arteria Carótida Interna , Estenosis Carotídea/tratamiento farmacológico , Inhibidores de Hidroximetilglutaril-CoA Reductasas/uso terapéutico , Mediadores de Inflamación/sangre , Embolia Intracraneal/prevención & control , Complicaciones Posoperatorias/prevención & control , Arteria Carótida Interna/inmunología , Estenosis Carotídea/inmunología , LDL-Colesterol/sangre , Colagenasas/sangre , Endarterectomía Carotidea , Humanos , Embolia Intracraneal/inmunología , Macrófagos/inmunología , Complicaciones Posoperatorias/inmunología , Factores de Riesgo , Inhibidores Tisulares de Metaloproteinasas/sangre

Asunto(s)

Fibrilación Atrial/complicaciones , Proteína C-Reactiva/metabolismo , Embolia Intracraneal/inmunología , Trombofilia/complicaciones , Fibrilación Atrial/inmunología , Ecocardiografía Transesofágica , Atrios Cardíacos/inmunología , Humanos , Inflamación/complicaciones , Inflamación/inmunología , Interleucina-6/sangre , Embolia Intracraneal/prevención & control , Factores de Riesgo , Trombofilia/inmunología , Tromboplastina/metabolismo

RESUMEN

Vascular dysfunction and inflammatory processes may be early events in the pathology of Alzheimer's disease (AD). Even though amyloid beta-peptides (Abeta) play a prominent role in the initiation and progression of cellular dysfunction in AD, the precise in vivo actions of various Abeta-peptides has not been established. The cerebrovascular actions of the major Abeta-peptides (1-40) and (1-42) in live animals were investigated using an open cranial window technique. We show here that the Abeta-peptides cause vascular lesions, especially in the arterioles. In one set of experiments, leukocytes and platelets were tagged with Rhodamine 6G, soluble Abeta(1-40) infused intravenously for 2 minutes, and the vasculature video recorded for 90 minutes. In a second set of experiments, soluble Abeta(1-40) infusion was followed 30 minutes later by an infusion of soluble Abeta(1-42) and the vasculature recorded for 90 minutes. Fluorescent and transmission electron microscopic examinations demonstrated the following cerebrovascular action of Abeta-peptides: endothelial cell damage, leukocyte adhesion, platelet activation, thrombus formation, impeded blood flow, and smooth muscle cell damage. The vascular disruption observed were similar to those observed in the brains of some AD patients and may represent the initial phase of a vascular inflammatory response associated with cerebral amyloid angiopathy. The combination of Abeta(1-40) and (1-42) produced significantly more vascular disruption than Abeta(1-40) alone. Oral administration of conjugated estrogens in ovariectomized female rats protected them from the deleterious actions of Abeta-peptides. The reported protective effect of estrogen against AD may be mediated in part through prevention of cerebrovascular Abeta toxicity.

Asunto(s)

Enfermedad de Alzheimer/inmunología , Demencia Vascular/inmunología , Estrógenos Conjugados (USP)/uso terapéutico , Enfermedad de Alzheimer/tratamiento farmacológico , Enfermedad de Alzheimer/patología , Péptidos beta-Amiloides/sangre , Péptidos beta-Amiloides/fisiología , Animales , Barrera Hematoencefálica/inmunología , Adhesión Celular/inmunología , Angiopatía Amiloide Cerebral/tratamiento farmacológico , Angiopatía Amiloide Cerebral/inmunología , Angiopatía Amiloide Cerebral/patología , Demencia Vascular/tratamiento farmacológico , Demencia Vascular/patología , Endotelio Vascular/inmunología , Endotelio Vascular/patología , Femenino , Humanos , Embolia Intracraneal/inmunología , Embolia Intracraneal/patología , Leucocitos/inmunología , Microscopía Electrónica , Fragmentos de Péptidos/fisiología , Activación Plaquetaria/inmunología , Ratas

RESUMEN

OBJECTIVES: Increasing evidence points to the inflammatory character of atherosclerosis, and several parameters of inflammation have been proposed as cardiovascular risk markers. We analyzed associations among serum high-sensitivity C-reactive protein (hs-CRP) concentrations, carotid plaque structure, and immunocytology, and neurologic symptoms in patients with high-grade carotid stenosis. METHODS: This was a cross-sectional study in a referral center and institutional practice in hospitalized patients. The study included 62 patients with greater than 70% carotid stenosis treated surgically; 58% of patients had symptoms, and 42% did not. Serum hs-CRP concentrations were determined 48 hours before surgery; levels greater than 10 mg/L were considered pathologic. Histopathologic analysis (stable or unstable) and immunohistochemistry (macrophage count, T lymphocytes, activated T lymphocytes) were carried out on the atherosclerotic plaques. RESULTS: Median hs-CRP values were 7.6 mg/L (range, 0-165 mg/L). Median hs-CRP concentrations were higher in patients with unstable plaque (53.2%) than in patients with stable plaque (46.7%): 27.1 mg/L (range, 1.8-165 mg/L) versus 4.1 mg/L (range, 0.3-56 mg/L) (P <.001). Among patients with symptomatic disease, 81% had CRP concentrations significantly higher than CRP concentrations in patients with asymptomatic disease (P <.001). A statistically significant association was found between hs-CRP levels and the presence of macrophages (Spearman rank correlation [rho], 0.61, P <.001) and T lymphocytes in the plaque (Spearman rank correlation [rho], 0.52, P <.001). At logistic regression analysis, neurologic event and macrophages in the plaque were independently associated with unstable plaque. CONCLUSIONS: Increased hs-CRP levels may be related to the presence of macrophages and T lymphocytes in plaque, which is associated with the phenomena of instability that can lead to development of an ischemic event. Thus determination of circulating hs-CRP levels may be a useful additional marker of risk in patients with high-grade carotid stenosis.

Asunto(s)

Isquemia Encefálica/inmunología , Proteína C-Reactiva/análisis , Estenosis Carotídea/inmunología , Embolia Intracraneal/inmunología , Adulto , Anciano , Anciano de 80 o más Años , Biomarcadores/sangre , Isquemia Encefálica/etiología , Proteína C-Reactiva/inmunología , Estenosis Carotídea/sangre , Estenosis Carotídea/complicaciones , Estenosis Carotídea/cirugía , Estudios Transversales , Endarterectomía Carotidea , Femenino , Humanos , Embolia Intracraneal/etiología , Masculino , Persona de Mediana Edad , Valor Predictivo de las Pruebas , Factores de Riesgo

RESUMEN

Arterioarterial thromboembolism from extracranial internal carotid artery (ICA) stenosis is an important pathogenic mechanism of ischemic stroke. However, even a high-grade ICA stenosis carries a greatly variable annual risk of stroke, as high as 13% following a recent occurrence of transient or minor cerebral ischemia or as low as 1-2% in clinically asymptomatic patients. There is increasing evidence that inflammatory processes play a central role in atherosclerosis and particularly in plaque destabilization converting chronic atherosclerosis into an acute neurological disorder. In thromboendarterectomy specimens from patients with high-grade ICA stenoses, the extent of inflammatory infiltration and the expression of matrixmetalloproteinase-9 correlated to clinical and ultrasonic features of plaque destabilization such as cerebral microembolism. Inflammation might become a new therapeutic target in symptomatic carotid artery disease.

Asunto(s)

Estenosis Carotídea/inmunología , Embolia Intracraneal/inmunología , Metaloendopeptidasas/metabolismo , Linfocitos T/inmunología , Arteria Carótida Interna/inmunología , Arteria Carótida Interna/patología , Estenosis Carotídea/patología , Humanos , Embolia Intracraneal/patología , Macrófagos/inmunología , Macrófagos/patología , Linfocitos T/patología , Tromboplastina/metabolismo

Asunto(s)

Síndrome Antifosfolípido/complicaciones , Enfermedades Autoinmunes/complicaciones , Embolia Intracraneal/etiología , Trombosis Intracraneal/etiología , Trombofilia/etiología , Administración Oral , Anticoagulantes/efectos adversos , Anticoagulantes/uso terapéutico , Síndrome Antifosfolípido/inmunología , Aspirina/efectos adversos , Aspirina/uso terapéutico , Enfermedades Autoinmunes/inmunología , Hemorragia/inducido químicamente , Humanos , Relación Normalizada Internacional , Embolia Intracraneal/inmunología , Embolia Intracraneal/prevención & control , Trombosis Intracraneal/inmunología , Trombosis Intracraneal/prevención & control , Trombofilia/tratamiento farmacológico , Trombofilia/inmunología